Beneficial effect of zinc chloride and zinc ionophore pyrithione on attenuated cardioprotective potential of preconditioning phenomenon in STZ-induced diabetic rat heart

Perfusion (United Kingdom)

Volumn 31, Issue 4, 2016, Pages 334-342

  Jamwal, Sumit ^a   Kumar, Kushal ^a   Reddy, B V Krishna ^a  

^a ISF COLLEGE OF PHARMACY   (India)

Author keywords

diabetes mellitus; ischemic preconditioning; ischemic reperfusion injury; isolated heart; zinc chloride

Indexed keywords

CREATINE KINASE MB; GLYCOGEN SYNTHASE KINASE 3BETA; LACTATE DEHYDROGENASE; MYELOPEROXIDASE; PYRITHIONE ZINC; STREPTOZOCIN; TRIPHENYLTETRAZOLIUM; ZINC CHLORIDE; CARDIOTONIC AGENT; CHLORIDE; PYRIDINE DERIVATIVE; PYRITHIONE; THIOKETONE; ZINC DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; ENZYME RELEASE; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART INJURY; HEART PROTECTION; ISCHEMIC PRECONDITIONING; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; TREATMENT DURATION; ANIMAL; CARDIAC MUSCLE; DIABETIC COMPLICATION; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; WISTAR RAT;

ANIMALS; CARDIOTONIC AGENTS; CHLORIDES; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; PYRIDINES; RATS; RATS, WISTAR; THIONES; ZINC COMPOUNDS;

EID: 84971617585     PISSN: 02676591     EISSN: 1477111X     Source Type: Journal    
DOI: 10.1177/0267659115608935     Document Type: Article

References (45)

1. Gaziano TA,. Cardiovascular disease in the developing world and its cost-effective management. Circulation 2005; 112: 3547-3553.
2. Topol EJ, Calliff RM, Vandormael M, et al. The thrombolysis and angioplasty in myocardial infarction. A randomized trial of late reperfusion therapy for acute myocardial infarction. Circulation 1992; 85: 2090-2099.
3. Piper HM, Abdallah Y, Schafer C,. The first minutes of reperfusion: a window of opportunity for cardioprotection. Cardiovasc Res 2004; 16: 365-371.
4. Murry CE, Jennings JB, Reimer KA,. Preconditioning with ischaemia: a delay of lethal injury in ischaemic myocardium. Circulation 1986; 74: 1124-1136.
5. Balakumar P, Singh H, Singh M, et al. The impairment of preconditioning-mediated cardioprotection in pathological conditions. Pharmacol Res 2009; 60: 18-23.
6. Nakamura M, Wang N, Zhao Z, et al. Preconditioning decreases Bax expression, PMN accumulation and apoptosis in reperfused rat heart. Cardiovasc Res 2000; 45: 661-670.
7. Hausenloy DJ, Duchen M, Yellon DM,. Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury. Cardiovasc Res 2003; 60: 617-625.
8. Fryer RM, Pratt PF, Hsu AK, et al. Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection. J Pharmacol Exp Ther 2001; 296: 642-649.
9. Iliodromitis KE, Lazou A, Kremastinos DT,. Ischemic preconditioning: protection against myocardial necrosis and apoptosis. Vasc Health Risk Manag 2007; 3: 629-637.
10. Yadav HN, Singh M, Sharma PL,. Involvement of GSK-3β in attenuation of the cardioprotective effect of ischemic preconditioning in diabetic rat heart. Mol Cell Biochem 2010; 343: 75-81.
11. Tsang A, Hausenloy DJ, Mocanu MM, et al. Preconditioning the diabetic heart: the importance of Akt phosphorylation. Diabetes 2005; 54: 2360-2364.
12. Sivaraman V, Hausenloy DJ, Wynne AM, et al. Preconditioning the diabetic human myocardium. J Cell Mol Med 2010; 14; 740-1746.
13. Kersten JR, Montgomery MW, Ghassemi T,. Diabetes and hyperglycaemia impair activation of mitochondrial KATP channels. Am J Physiol 2001; 280: H1744-H1750.
14. Song P, Wu Y, Xu J, et al. Reactive nitrogen species induced by hyperglycaemia suppresses Akt signalling and triggers apoptosis by upregulating PTEN (phosphatase and tensin homologue deleted on chromosome 10) in an LKB1-dependent manner. Circulation 2007; 116: 1585-1595.
15. Siddall HK, Warrell CE, Yellon DM, et al. Ischemia-reperfusion injury and cardioprotection: investigating PTEN, the phosphatase that negatively regulates PI3K, using a congenital model of PTEN haploinsufficiency. Basic Res Cardiol 2008; 103: 560-568.
16. Mensah K, Mocanu MM, Yellon DM,. Failure to protect myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: a potential role for phosphatase and tensin homolog deleted on chromosome ten? J Am Coll Cardiol 2005; 45: 1287-1291.
17. Singh RB, Gupta UC, Mittal N,. Epidemiologic study of trace elements and magnesium on risk of coronary artery disease in rural and urban Indian populations. J Am Coll Nutr 1997; 16: 62-67.
18. Chausmer AB,. Zinc, insulin and diabetes. J Am Coll Nutr 1998; 17: 109-115.
19. Devirgiliis C, Zalewski PD, Perozzi G, et al. Zinc fluxes and zinc transporter genes in chronic diseases. Mutat Res 2007; 622: 84-93.
20. Ilouz R, Kaidanovich O, Gurwitz D, et al. Inhibition of glycogen synthase kinase-3b by bivalent zinc ions: insight into the insulin-mimetic action of zinc. Biochem Bioph Res Co 2002; 295: 102-106.
21. Chanoit G, Lee S, Xi J, et al. Exogenous zinc protects cardiac cells from reperfusion injury by targeting mitochondrial permeability transition pore through inactivation of glycogen synthase kinase-3β. Am J Physiol 2008; 295: H1227-H1233.
22. Trinder P,. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 1969; 6: 24.
23. King JA,. A routine method for estimation of lactate dehydrogenase activity. J Med Lab Tech 1959; 16: 265-272.
24. Hughes BP,. A method for the estimation of serum creatine kinase and aldose activity in the normal and pathological sera. Clin Chim Acta 1961; 7: 597-603.
25. Fishbein MC, Meerbaum S, Rit J, et al. Early phase acute myocardial infarct size quantification: validation of the triphenyltetrazolium chloride tissue enzyme staining technique. Am Heart J 1981; 101: 593-600.
26. Chopra K, Singh M, Kaul N, et al. Decrease of myocardial infarct size with desferrioxamine. Possible role of oxygen free radicals in its ameliorative effect. Mol Cell Biochem 1992; 113: 71-76.
27. Ferdinandy P, Szilvassy Z, Baxter GF,. Adaptation to myocardial stress in disease states: is preconditioning a healthy heart phenomenon. Trends Pharmacol Sci 1998; 19: 223-229.
28. Shi-Ting W, Mang-Hua X, Wen-Ting C, et al. Study on tolerance to ischemia-reperfusion injury and protection of ischemic preconditioning of type 1 diabetes rat heart. Biomed Pharmacother 2011; 1: 56-60.
29. Ravingerova T, Stetka R, Volkovova K, et al. Acute diabetes modulates response to ischemia in isolated rat heart. Mol Cell Biochem 2011; 210: 143-151.
30. Lindeman RD, Yunice AA, Baxter DJ, et al. Myocardial zinc metabolism in experimental myocardial infarction. J Lab Clin Med 1973; 81: 194-204.
31. Karagulova G, Yue Y, Moreyra A, et al. Protective role of intracellular zinc in myocardial ischemia/reperfusion is associated with preservation of protein kinase C isoforms. JPET 2007; 321: 517-525.
32. Baines CP, Song CX, Zheng YT,. Protein kinase C epsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ Res 2003; 92: 873-880.
33. Inagaki K, Chen L, Ikeno F,. Inhibition of delta-protein kinase C protects against reperfusion injury of the ischemic heart in vivo. Circulation 2003; 108: 2304-2307.
34. Koya D, King G,. Protein kinase C activation and the development of diabetic complications. Diabetes 1998; 47: 859-866.
35. Chou SS, Clegg MS, Momma TY, et al. Alterations in protein kinase C activity and processing during zinc-deficiency-induced cell death. Biochem J 2004; 383: 63-71.
36. Mclntosh R, Lee SR, Ghio AJ, et al. The critical role of intracellular zinc in adenosine A2 receptor activation induced cardioprotection against reperfusion injury. J Mol Cell Cardiol 2010; 49: 41-47.
37. Powell SR, Hall D, Aiuto L, et al. Zinc improves postischemic recovery of the isolated rat heart through inhibition of oxidative stress. Am J Physiol 1994; 266: H2497-H24507.
38. Chanoit G, Lee S, Xi J, et al. Exogenous zinc protects cardiac cells from reperfusion injury by targeting mitochondrial permeability transition pore through inactivation of glycogen synthase kinase-3β. Am J Physiol 2008; 295: H1227-H1233.
39. Lee S, Chanoit G, McIntosh R, et al. Molecular mechanism underlying Akt activation in zinc induced cardioprotection. Am J Physiol 2009; 297: H569-H575.
40. Argaud L, Gateau-Roesch O, Muntean D,. Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury. J Mol Cell Cardiol 2005a; 38: 367-374.
41. Griffiths EJ, Halestrap AP,. Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J 1995; 307: 93-98.
42. ATP channels function. J Physiol 2004; 559: 157-167.
43. Cohen MV, Baines CP, Downey JM,. Ischemic preconditioning: from adenosine receptor to KATP channel. Annu Rev Physiol 2000; 62: 79-109.
44. Kasi V, Bodiga S, Kommuguri UN,. Zinc pyrithione salvages reperfusion injury by inhibiting NADPH oxidase activation in cardiomyocytes. Biochem Biophys Res Co 2003; 410: 270-275.
45. Kasi V, Bodiga S, Bolagun V, et al. Cardioprotective effect of zinc requires ErbB2 and Akt during hypoxia/reoxygenation. Biometals 2011; 24: 171-180.